Skip to content

Top gainers Top losers Most active Market sectors Heatmap Treasury rates

Earnings calendar IPO calendar Ex-dividend calendar Economic calendar

Congress trades Insider trades Analyst upgrades & downgrades

Screener Compare Backtester

Valuation Fundamentals

Watchlist Portfolio

⌕/

Markets

Stocks Gainers Losers Most active Market sectors Heatmap Earnings calendar Congress trades Insider trades Analyst upgrades/downgrades IPO calendar Ex-dividend calendar

Tools

Screener Compare stocks Returns backtester Portfolio tracker Watchlist Embeddable widget

Metrics

Valuation Fundamentals

Popular lists

Best dividend stocks Best value stocks Largest companies Lowest P/E stocks

Collections

All lists & collections US stocks Japanese stocks Chinese stocks Hong Kong stocks South Korean stocks Taiwanese stocks Canadian stocks UK stocks European stocks Magnificent 7 AI stocks Semiconductor stocks

Compare

Compare stocks Finviz alternative Koyfin alternative TradingView alternative StockAnalysis alternative

Learn

Investing glossary Help & guide

StockMarketCapDocs Token Terms PrivacyData for information only, not investment advice.

◆

BeOne Medicines AG (ONC) News - StockMarketCap

Stocks›BeOne Medicines AG☆

● At closeAs of Jul 2, 2026

BeOne Medicines AG

ONC✓

HealthcareBiotechnologyNASDAQ

$297.65+2.38%

$31.81BMarket cap

4.80xP/E ratio

291.89KVolume (24h)

Overview Forecast Valuation Financials Technical Dividends Smart money News

Price

$297.65

$6.91 (+2.38%) · 24h

Key metrics

Market cap$31.81B+1.89%

Enterprise value$37.52B

Volume (24h)291.89K

P/E ratio (TTM)4.80x

P/S ratio (TTM)6.99x

Dividend yield0.00%

Shares outstanding106.86M

Trading range

Previous close$290.74

Day range$291.87 - $300.11

52-week range$239.25 - $385.22

BeOne Medicines AG (ONC) operates in the Biotechnology industry within the Healthcare sector, listed on NASDAQ.

Similar stocks

Eli Lilly and Company+1.57%

Johnson & Johnson+3.57%

AbbVie Inc.+3.99%

UnitedHealth Group Incorporated-0.28%

Roche Holding AG+3.89%

Merck & Co., Inc.+3.31%

Latest news